Home / Central Data Catalog / IMPACT_EVALUATION / BEN_2010_HRBF_V01_M_V01_A_PUF / variable [F45]
impact_evaluation

Health Results-Based Financing Impact Evaluation Survey 2010-2011, Baseline

Benin, 2010 - 2011
Get Microdata
Reference ID
BEN_2010_HRBF_v01_M_v01_A_PUF
DOI
https://doi.org/10.48529/qkmg-r734
Producer(s)
Christophe Lemière and Damien de Walque
Collection(s)
Impact Evaluation Surveys
Metadata
Documentation in PDF DDI/XML JSON
Created on
Oct 20, 2014
Last modified
Oct 21, 2014
Page views
520002
Downloads
15610

3.1. dosage (j2) (k3_3_1_j2_w)

Data file: benhrbf2_k3_2

Overview

Valid: 228
Invalid: 0
Type: Discrete
Start: 38
End: 66
Width: 29
Range: -
Format: character

Questions and instructions

Categories
Value Category Cases
1 1
0.4%
10% 500U 1
0.4%
100 MG 3
1.3%
100 MG COMP 1
0.4%
100MG 5
2.2%
100MG COMP 5
2.2%
100MG COMPRIMES 2
0.9%
100MG CP 5
2.2%
100MG SIROP 1
0.4%
10CC 1
0.4%
10MG 4
1.8%
10MG AMP 1
0.4%
10MG COMPRIMES 1
0.4%
10MG CP 1
0.4%
10ML 3
1.3%
10U 1
0.4%
120MG 12 CP 1
0.4%
120MG 18 1
0.4%
120MG 18 CP 1
0.4%
120MG 18CP 1
0.4%
120MG 24 1
0.4%
120MG 24 CP 1
0.4%
120MG 6 CP 1
0.4%
125MG 1
0.4%
125MG SIROP 1
0.4%
12CP 20/120MG 2
0.9%
15 MG 1
0.4%
1G 1
0.4%
1G AMP 1
0.4%
1G FLACON 3
1.3%
1G INJ 1
0.4%
1G INJECTABLE 1
0.4%
1MUI 1
0.4%
2 ML 1
0.4%
200 MG 2
0.9%
200MG 6
2.6%
200MG CP 2
0.9%
20MG 4
1.8%
20MG COMPRIMES 1
0.4%
20MG CP 1
0.4%
20MG/120MG 2
0.9%
20MG/120MG BLISTER DE 12 COMP 1
0.4%
240MG SUPPO 1
0.4%
250 MG 3
1.3%
250 MG COMP 1
0.4%
2500000 UI 1
0.4%
250MG 7
3.1%
250MG COMP 2
0.9%
250MG CP 2
0.9%
250MG SUSPENSION 1
0.4%
250MG/5ML 1
0.4%
25MG 67.5 COMPRIMES 1
0.4%
2ML 1
0.4%
30 1
0.4%
300 MG 1
0.4%
300 MG COMP 2
0.9%
300MG 3
1.3%
300MG COMP 2
0.9%
300MG COMPRIMES 1
0.4%
300MG CP 3
1.3%
400 MG COMP 1
0.4%
400MG 3
1.3%
400MG COMP 1
0.4%
400MG CP 2
0.9%
480 MG 1
0.4%
480 MG COMP 1
0.4%
480MG 2
0.9%
480MG COMP 1
0.4%
480MG CP 1
0.4%
4MG 1
0.4%
4MG AMP 1
0.4%
5 CC 1
0.4%
5 MG 1
0.4%
500 MG 6
2.6%
500 MG COMP 3
1.3%
500 MG COMPS 1
0.4%
500 MG INJ 1
0.4%
500 MG-62.5 MG 1
0.4%
500 MG/62.5 MG COMP 1
0.4%
500MG 26
11.4%
500MG COMP 6
2.6%
500MG COMPRIMES 6
2.6%
500MG CP 8
3.5%
500MG INJECTABLE 1
0.4%
500MG/62.5MG 1
0.4%
500ML 5% 1
0.4%
500ML/10% 1
0.4%
50MG 1
0.4%
5CC 3
1.3%
5MG 11
4.8%
5MG COMP 1
0.4%
5MG CP 2
0.9%
5ML 1
0.4%
600 MG INJ 1
0.4%
6CP 1
0.4%
6MG 1
0.4%
80MG 2
0.9%
80MG INJ 1
0.4%
80MG INJECTABLE 1
0.4%
AMP 1
0.4%
AMPOULE 2
0.9%
BLISTER6 1
0.4%
COMP 1
0.4%
COMP 500MG 1
0.4%
CP 3
1.3%
DE 10ML 1
0.4%
SIROP FLACON 1
0.4%
SROP 250MG 1
0.4%
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.
Back to Catalog

This site uses cookies to optimize functionality and give you the best possible experience. If you continue to navigate this website beyond this page, cookies will be placed on your browser. To learn more about cookies, click here.